Innovation is not an abstract concept, it means being able to manage, cure and prevent diseases. The results are real lives of real people transformed. And #WeWontRest until patients everywhere can see the results, in black and white: https://t.co/8B20iIigcG
Σήμερα στην Ελλάδα, μόνο 1 στα 5 καινοτόμα φάρμακα φτάνει εγκαίρως στους ασθενείς, με καθυστερήσεις που ξεπερνούν τον ευρωπαϊκό μέσο όρο. Αυτό σημαίνει ότι πολλοί ασθενείς περιμένουν περισσότερο ή δεν έχουν καθόλου πρόσβαση σε θεραπείες που θα μπορούσαν να βελτιώσουν ή και να σώσουν τη ζωή τους.
Άμεση εξασφάλιση των καινοτόμων θεραπειών σημαίνει:
◆ Ταχύτερη πρόσβαση σε νέες θεραπείες υψηλής αξίας
◆ Πιο βιώσιμο και αποτελεσματικό σύστημα υγείας
◆ Περισσότερη έρευνα, επενδύσεις και πρόοδο
Παραμονή των ασθενών χωρίς νέες θεραπείες σημαίνει:
× Συνεχείς καθυστερήσεις στην πρόσβαση στα νέα φάρμακα
× Η χώρα μένει πίσω στην ιατρική καινοτομία
× Χάνονται ευκαιρίες για ασθενείς, υγεία και οικονομία
Ποια θα είναι η επιλογή;
Μάθετε περισσότερα: https://t.co/1Bb38ynsTj
#SFEE #EuropesChoice #GreecesChoice #WeWontRest @EFPIA
#Colorectal#cancer is one of the most preventable #cancers. It typically develops from polyps that can be detected & removed before they become cancerous.
Don't ignore changes in your bowel habits and talk to your doctor about when to begin #ColorectalCancer screenings.
Thank you Commissioner @MarosSefcovic for this important meeting with our the @efpia Board and for your clear commitment. Together we can ensure the #EU’s #healthsecurity in any circumstance
An important exchange with @EFPIA representatives. The EU's pharmaceutical industry is a strategic part of our economy, driving innovation. Together, we aim to fortify Europe's medicines supply chains - the @EU_Commission is fully committed.
Europe will never give up on its health industry.
Firm commitment to keep our innovation and manufacturing in Europe.
Continued engagement with the industry incl. @EFPIA Board today.
📢 With @medicinesforEU & @EFPIA, we have published recommendations on electronic product information (#ePI), addressing key topics such as:
🔹 Moving towards ePI
🔹 Content
🔹 Key considerations for #EUPharmaLegislation
🔹 and much more!
➡️ Read +: https://t.co/3wYJDiSDPn
The afternoon at #POLITICOHealthCare Summit kicks off with opening remarks by @EFPIA’s Nathalie Moll, and a spotlight interview with Jakub Dvořáček. 🗣️
Don’t miss out! 🔴 https://t.co/u4yIgNzIkA
🚀 Join us for the ERDERA launch event!
🗓️ 28 Oct 2024
⏰ 14:00-16:15 CET
💻 Online
Don't miss insights from top experts & learn how @ERDERA_org is set to change the landscape of rare diseases research!
👉 RSVP here:https://t.co/Xb3trTuebd
#RareDiseases@EU_HaDEA
Wiceminister @ignacyn uczestniczył w posiedzeniu grupy roboczej @EFPIA CEE Task Force. Grupa, w skład której wchodzą przedstawiciele firm farmaceutycznych z regionu Europy Środkowej i Wschodniej, prowadzi regularny dialog na temat rozwoju branży farmaceutycznej oraz wyzwań regulacyjnych. Uczestnicy spotkania rozmawiali m. in. o zaangażowaniu innowacyjnych technologii w rozwój branży farmaceutycznej.
1/2
”Mitä jos Eurooppa olisikin se maanosa, joka ehkäisee seuraavan pandemian, kehittää Alzheimerin tautia hidastavat hoidot tai muuttaa kroonisia tauteja sairastavien potilaiden elämän?”
@NathalieMoll @EFPIA 🇪🇺
@KauppalehtiFi https://t.co/k9L32g5C9X
@NathalieMoll - patient engagement is crucial for medicines development for pharma companies to understand where there are unmet needs and what’s important for different patient groups @EFPIA#Vote4Patients
.@NathalieMoll, Director General at @EFPIA, adds:
"There is a need for connectivity and coherence between the different legislations to make sure we make the most of the data and the information that we gather."
#Vote4Patients
The key takeaways from the Rethinking #Alzheimer's Disease Perspective Paper:
🔎 Recognise the benefits of improved patient outcomes
🏥 Improve access to innovative treatments & holistic care
✔️ Build trust to allow for the implementation of guidelines
🔗https://t.co/SYjSKxgaXl
💡 Looking for partners for a potential call 9 project? To pitch at our F2F 𝗯𝗿𝗼𝗸𝗲𝗿𝗮𝗴𝗲 𝗲𝘃𝗲𝗻𝘁 𝗼𝗻 𝟭𝟮-𝟭𝟯 𝗡𝗼𝘃, 𝗽𝘂𝗯𝗹𝗶𝘀𝗵 𝘆𝗼𝘂𝗿 𝗽𝗿𝗼𝗽𝗼𝘀𝗮𝗹 on our online platform by 𝟮𝟴 𝗢𝗰𝘁.⏰ https://t.co/zIQGW5wMQC #IHITransformingHealth#ResearchFunding
Roberta Savli, executive director of Public Affairs, European Federation of Pharmaceutical Industries and Associations (@EFPIA), interviene en #ObservatoriodelaSanidad
🔴En directo: https://t.co/bqxnm8QCOV
Pedro Facon @PedroFacon Belgian INAMI - the value assessments when introducing new medicines are more thorough than when we introduce other types of healthcare interventions and service models #EHFG@GasteinForum@EFPIA